Cover Image
Market Research Report
Product code
1018674

Europe Alopecia (Hair Loss) Treatment Market Forecast 2021-2028

Published: | Inkwood Research | 135 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Alopecia (Hair Loss) Treatment Market Forecast 2021-2028
Published: July 19, 2021
Inkwood Research
Content info: 135 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Europe alopecia (hair loss) treatment market is evaluated to record a CAGR of 4.45% during the projected years of 2021 to 2028. Factors such as the surging geriatric population, the increased incidence of autoimmune conditions, the high levels of alcohol consumption and smoking, and changing lifestyle patterns propel the regional market's growth.

MARKET INSIGHTS

The Europe alopecia (hair loss) treatment market growth evaluation includes the assessment of France, Poland, Germany, Italy, Russia, the United Kingdom, Belgium, and the rest of Europe. The French culture is characterized by important aspects such as grooming and fashion. Consumers in France are highly conscious in terms of their appearances and looks, resulting in increased expenditure on personal care products. Moreover, the country also has world-class hair clinics equipped with technologically advanced solutions as well as hair growth brands for treating hair loss. However, according to statistics, France's balding rate is significantly high and affects 40% of men.

On the other hand, Italy houses leading pharmaceutical firms like Cassiopea, focusing on the research for treating alopecia. The country also has a competitive market for hair regrowth products, including topical solutions. Besides, hair clinics providing therapies for hair growth, laser techniques, and grafting are garnering lucrative growth opportunities, as well. Increased expenditure on personal care and consumer awareness regarding hair growth product quality is also vital for the French market's development. Hence, these factors are set to drive the Europe alopecia (hair loss) treatment market growth during the forecasting period.

COMPETITIVE INSIGHTS

Some of the key companies operating in the market are: Cassiopea, L'Oreal, DHI Global, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 23925

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISE IN AUTOIMMUNE DISEASES
    • 3.1.2. HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
    • 3.1.3. UNHEALTHY DIETARY HABITS
    • 3.1.4. STRESS AND CHANGING LIFESTYLES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISK OF INFECTIONS OR SIDE EFFECTS
    • 3.2.2. HIGH COSTS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY GENDER

  • 5.1. FEMALE
  • 5.2. MALE

6. MARKET BY INDICATIONS

  • 6.1. ANDROGENIC ALOPECIA
  • 6.2. ALOPECIA AREATA
  • 6.3. ALOPECIA TOTALIS
  • 6.4. OTHER INDICATIONS

7. MARKET BY DISTRIBUTION CHANNELS

  • 7.1. DRUG STORES & RETAIL PHARMACIES
  • 7.2. HOSPITAL PHARMACIES
  • 7.3. ONLINE PHARMACIES

8. MARKET BY TREATMENT

  • 8.1. TOPICAL
    • 8.1.1. MINOXIDIL
    • 8.1.2. SHAMPOOS
  • 8.2. ORAL
    • 8.2.1. FINASTERIDE
    • 8.2.2. OTHER ORAL HAIR LOSS TREATMENT
  • 8.3. OTHER TREATMENT TYPES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. EUROPE
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED KINGDOM
      • 9.1.5.2. GERMANY
      • 9.1.5.3. FRANCE
      • 9.1.5.4. ITALY
      • 9.1.5.5. RUSSIA
      • 9.1.5.6. BELGIUM
      • 9.1.5.7. POLAND
      • 9.1.5.8. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS & AGREEMENTS
    • 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 10.2. COMPANY PROFILES
    • 10.2.1. ACLARIS THERAPEUTICS
    • 10.2.2. CELLMID
    • 10.2.3. CIPLA LTD
    • 10.2.4. CONCERT PHARMACEUTICALS
    • 10.2.5. DAIICHI SANKYO
    • 10.2.6. DR. REDDY'S LABORATORIES
    • 10.2.7. JOHNSON AND JOHNSON
    • 10.2.8. LEXINGTON INTERNATIONAL
    • 10.2.9. MERK & CO INC
    • 10.2.10. SHISEIDO COMPANY LIMITED
    • 10.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
    • 10.2.12. TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
    • 10.2.13. TEVA PHARMACEUTICALS INDUSTRIES LTD
    • 10.2.14. THE HIMALAYA DRUG COMPANY
    • 10.2.15. TRANSITION HAIR PVT LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 2: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: EUROPE L ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: LEADING PLAYERS OPERATING IN EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 17: LIST OF MERGERS & ACQUISITIONS
  • TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
  • FIGURE 7: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020
  • FIGURE 10: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020
  • FIGURE 15: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020
  • FIGURE 19: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 21: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
  • FIGURE 22: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
  • FIGURE 24: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 25: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
  • FIGURE 26: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 27: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 28: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 29: UNITED KINGDOM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GERMANY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: FRANCE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: ITALY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: RUSSIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: BELGIUM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: POLAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: REST OF EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)